Product Images Candesartan Cilexetil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Candesartan Cilexetil NDC 46708-341 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

30' bottle pack - candesartan 16

30' bottle pack - candesartan 16

This is a description of Candesartan Cikexetl, USP 16mg tablets, manufactured by Alembic Pharmaceuticals Limited in India. The usual adult dosage is not mentioned, and one should see the package for it. The tablets should be stored at a temperature of 25°C (77°F), and excursions are permitted between 10-15°C to 30°C (59° to 86°F). The tablets are available in packages of 30 and require a prescription to be dispensed. The lot number mentioned is BXP.*

30' bottle pack - candesartan 4

30' bottle pack - candesartan 4

Each tablet contains 4 mg of Candesartan Cilexeti, USP. It is an uncoated tablet and the usual adult dosage is not provided. The tablets should be stored between 15° to 30°C (59° to 86°F). It is manufactured by Alembic Pharmaceuticals Limited and the NDC code is 46708-341-30. The tablets come in a container of 30 tablets and the prescription is required. The text also provides information about the manufacturer's address, and the lot number but does not provide a useful description.*

30' bottle pack - candesartan 8

30' bottle pack - candesartan 8

Each tablet contains 8mg of Candesartan Cikexetil. The usual adult dosage can be found in the package insert. The tablets should be stored between 15-30°C. The manufacturer is Alembic Pharmaceuticals Limited located in Gujarat, India. The tablets are sold in boxes containing 30 tablets and are only available with a prescription. The lot number is not available.*

Figure - candesartan fig

Figure - candesartan fig

This appears to be a tabular data showing patients' demographics and medical history variables such as age, sex, race, NYHA, LVEF, diabetes, hypertension, previous MI, atrial fibrillation, medications like ACE inhibitor, B-blocker, spironolactone, diuretic, digitalis, aspirin, and lipid-lowering. The table also presents a comparison between the groups of patients treated with Candesartan or Placebo. There is a column showing Hazard Ratio (95% CI) and years from 2004 to 2013. Therefore, this could be a medical study evaluating the effectiveness of Candesartan in comparison to Placebo on patients with the listed medical history variables.*

Structure - candesartan str

Structure - candesartan str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.